Skip to main content
Premium Trial:

Request an Annual Quote

Cyntellect Snares US Biopharma Customer for Cell Xpress Service

NEW YORK, Feb. 1 (GenomeWeb News) - San Diego-based Cyntellect said recently that an undisclosed US-based biotechnology company has entered into a formal agreement with Cyntellect to access its Cell Xpress service.


The agreement is the second one announced by Cyntellect since the service was launched in October 2004, when the company also said it had signed a partnership for Cell Xpress with Protein Design Labs.


Cyntellect's LEAP (Laser-Enabled Analysis and Processing) platform, which is part of the company's Cell Xpress service, allows researchers to image and measure protein secretions in situ in high-throughput on individual cells, as well as use laser-based elimination of undesired cells.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.